Gerecht and Mao to join INBT leadership effective January 1

The Johns Hopkins Institute for NanoBioTechnology (INBT) recently announced that Sharon Gerecht and Hai-Quan Mao have been appointed as associate directors, effective January 1, 2016.

“The addition of Gerecht and Mao to the Institute’s leadership team will be crucial in developing new research areas,” says director Peter C. Searson, the Joseph R. and Lynn C. Reynolds Professor in Materials Science and Engineering at the Whiting School.

mao-gerecht

Hai-Quan Mao and Sharon Gerecht join INBT as associate directors in 2016

Associate director Denis Wirtz, Vice Provost for Research and the Theophilus H. Smoot Professor of Chemical and Biomolecular Engineering adds, “Their broad research interests and forward-thinking vision will contribute to shaping the institute’s future.”

Both Gerecht and Mao are engaged in collaborative projects with investigators in Johns Hopkins University’s School of Medicine, Bloomberg School of Public Health, and Krieger School of Arts and Sciences, and the university’s Applied Physics Laboratory.

Gerecht, the Kent Gordon Croft Investment Management Faculty Scholar and an associate professor of chemical and biomolecular engineering, has been a member of the INBT since arriving at Johns Hopkins in 2007. Gerecht’s research interests include stem cell differentiation, biomaterials development and tissue engineering approaches for regenerative medicine and cancer. In 2015, Gerecht received the inaugural President’s Frontier Award from Johns Hopkins University, in recognition of her scholarly achievements and exceptional promise.

Mao, a professor of materials science and engineering, has been active in INBT since its inception in 2006.  Mao holds joint appointments in the Translational Tissue Engineering Center in the School of Medicine and the Whitaker Biomedical Engineering Institute. His research focuses on creating nanofiber matrix platforms to direct stem cell expansion and differentiation, nanomaterials to modulate the immunoenvironment and promote neural regeneration, and developing nanoparticle systems to deliver plasmid DNA, siRNA, vaccines and other therapeutic agents.

“INBT has been instrumental in advancing science and engineering in critically important areas of research,” says Ed Schlesinger, the Benjamin T. Rome Dean of the Whiting School of Engineering. “An additional manifestation of the INBT’s success and growth is the astonishingly talented faculty who are part of the institute and who are willing and able to take on leadership roles. I have no doubt that in their new roles Sharon and Hai-Quan will help advance the INBT’s mission and its stellar reputation.”

INBT was launched in 2006 with support from Senator Barbara Mikulski to promote multidisciplinary research at the interface of nanotechnology and medicine.  The institute, with more than 250 affiliated faculty members from the Johns Hopkins University’s School of Medicine, Whiting School of Engineering, Krieger School of Arts and Sciences, School of Education, Bloomberg School of Public Heath, and the Applied Physics Laboratory, is home to several center grants and numerous education, training, and outreach programs.

All press inquiries about this program or about INBT in general should be directed to Mary Spiro, INBT’s science writer and media relations director at mspiroATjhu.edu.

Leave a Comment

*